Phytohealth Corp (4108) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.003x

Based on the latest financial reports, Phytohealth Corp (4108) has a cash flow conversion efficiency ratio of -0.003x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-5.92 Million ≈ $-186.54K USD) by net assets (NT$2.29 Billion ≈ $72.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Phytohealth Corp balance sheet independence to measure how much of total assets are equity-financed.

Phytohealth Corp - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Phytohealth Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Phytohealth Corp to evaluate the quality of earnings relative to operating cash generation.

Phytohealth Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Phytohealth Corp ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
ADVENICA AB
F:65R
0.098x
Sab Zenzele Kabili Holdings
JSE:SZK
0.020x
e-LITECOM CO. Ltd
KQ:041520
-0.006x
Foshan Electrical and Lighting Co Ltd
SHE:200541
0.012x
Great Elm Capital Corp
NASDAQ:GECC
0.219x
Makarony Polskie S.A.
WAR:MAK
0.058x
WINS Co. Ltd
KQ:136540
0.022x
BARK, Inc.
NYSE:BARK
0.021x

Annual Cash Flow Conversion Efficiency for Phytohealth Corp (2005–2025)

The table below shows the annual cash flow conversion efficiency of Phytohealth Corp from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see 4108 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$2.29 Billion
≈ $72.26 Million
NT$-39.72 Million
≈ $-1.25 Million
-0.017x +18.20%
2024-12-31 NT$2.37 Billion
≈ $74.62 Million
NT$-50.13 Million
≈ $-1.58 Million
-0.021x +12.24%
2023-12-31 NT$2.27 Billion
≈ $71.54 Million
NT$-54.77 Million
≈ $-1.73 Million
-0.024x +8.36%
2022-12-31 NT$2.28 Billion
≈ $71.75 Million
NT$-59.95 Million
≈ $-1.89 Million
-0.026x +7.86%
2021-12-31 NT$2.39 Billion
≈ $75.25 Million
NT$-68.24 Million
≈ $-2.15 Million
-0.029x +67.11%
2020-12-31 NT$1.70 Billion
≈ $53.63 Million
NT$-147.87 Million
≈ $-4.66 Million
-0.087x -25.30%
2019-12-31 NT$1.75 Billion
≈ $55.19 Million
NT$-121.45 Million
≈ $-3.83 Million
-0.069x +4.67%
2018-12-31 NT$1.94 Billion
≈ $61.27 Million
NT$-141.44 Million
≈ $-4.46 Million
-0.073x +0.29%
2017-12-31 NT$2.08 Billion
≈ $65.45 Million
NT$-151.52 Million
≈ $-4.77 Million
-0.073x +77.69%
2016-12-31 NT$2.32 Billion
≈ $72.95 Million
NT$-756.87 Million
≈ $-23.85 Million
-0.327x -472.14%
2015-12-31 NT$2.30 Billion
≈ $72.36 Million
NT$-131.22 Million
≈ $-4.13 Million
-0.057x -304.42%
2014-12-31 NT$2.39 Billion
≈ $75.25 Million
NT$-33.74 Million
≈ $-1.06 Million
-0.014x +68.58%
2013-12-31 NT$2.74 Billion
≈ $86.30 Million
NT$-123.18 Million
≈ $-3.88 Million
-0.045x +23.87%
2012-12-31 NT$2.78 Billion
≈ $87.67 Million
NT$-164.37 Million
≈ $-5.18 Million
-0.059x +46.05%
2011-12-31 NT$1.56 Billion
≈ $49.24 Million
NT$-171.09 Million
≈ $-5.39 Million
-0.109x -3.32%
2010-12-31 NT$1.82 Billion
≈ $57.41 Million
NT$-193.06 Million
≈ $-6.08 Million
-0.106x -98.88%
2009-12-31 NT$2.01 Billion
≈ $63.36 Million
NT$-107.15 Million
≈ $-3.38 Million
-0.053x -181.31%
2006-12-31 NT$1.32 Billion
≈ $41.63 Million
NT$86.57 Million
≈ $2.73 Million
0.066x +30.10%
2005-12-31 NT$1.19 Billion
≈ $37.44 Million
NT$59.85 Million
≈ $1.89 Million
0.050x --

About Phytohealth Corp

TW:4108 Taiwan Drug Manufacturers - Specialty & Generic
Market Cap
$73.21 Million
NT$2.32 Billion TWD
Market Cap Rank
#20395 Global
#1210 in Taiwan
Share Price
NT$11.70
Change (1 day)
+0.43%
52-Week Range
NT$11.55 - NT$17.30
All Time High
NT$46.36
About

PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. … Read more